Surrozen (SRZN) 10-K/A 14 May 21 2020 FY Annual report (amended) Financial data

Cover Page

Cover Page - USD ($)	4 Months Ended
	Dec. 31, 2020	Mar. 01, 2021	Jun. 30, 2020
Document and Entity Information
Document Type	10-K/A
Document Period End Date	Dec. 31, 2020
Entity Registrant Name	CONSONANCE-HFW ACQUISITION CORP.
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Public Float			$ 0
Entity Central Index Key	0001824893
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Amendment Flag	true
Document Transition Report	false
Entity Address, State or Province	NJ
Document Annual Report	true
Amendment Description	Consonance-HFW Acquisition Corp. (the “Company,” “we”, “our” or “us”) is filing this Annual Report on Form 10-K/A (Amendment No. 2), or this Annual Report, to amend our Annual Report on Form 10-K for the period ended December 31, 2020, originally filed with the Securities and Exchange Commission, or the SEC, on March 31, 2021, or the Original Filing, to restate our consolidated financial statements for the period ended December 31, 2020. The restatement results from the Company’s prior accounting for its outstanding warrants issued in connection with its initial public offering in November 2020 as components of equity instead of as derivative liabilities. The warrant agreement governing the warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. In addition, the warrant agreement includes a provision that in the event of a tender or exchange offer made to and accepted by holders of more than 50% of the outstanding shares of a single class of ordinary shares, all holders of the warrants would be entitled to receive cash for their warrants (the “tender offer provision”). In other words, in the event of a qualifying cash tender offer (which could be outside the control of the Company), all warrant holders would be entitled to cash, while only certain of the holders of the underlying ordinary shares would be entitled to cash. In connection with the audit of the Company’s financial statements for the period ended December 31, 2020, the Company’s management further evaluated the warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Contracts in Entity’s Own Equity. ASC Section 815-40-15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s common stock. Under ASC Section 815-40-15, a warrant is not indexed to the issuer’s common stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant. Based on management’s evaluation, the Company’s audit committee, in consultation with management and after discussion with the Company’s independent registered public accounting firm, concluded that the Company’s warrants are not indexed to the Company’s ordinary shares in the manner contemplated by ASC Section 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. In addition, based on management’s evaluation, the Company’s audit committee, in consultation with management and after discussion with the Company’s independent registered public accounting firm, concluded the tender offer provision included in the warrant agreement fails the “classified in shareholders’ equity” criteria as contemplated by ASC Section 815-40-25. As a result of the above, the Company should have classified the warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period. The Company’s accounting for the warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported operating expenses, cash flows or cash. In connection with the restatement, the Company’s management reassessed the effectiveness of its disclosure controls and procedures for the periods affected by the restatement. As a result of that reassessment, the Company’s management determined that its disclosure controls and procedures for such periods were not effective with respect to the classification of the Company’s warrants as components of equity instead of as derivative liabilities. For more information, see Item 9A included in this Annual Report on Form 10-K. The Company has not amended its previously filed Current Report on Form 8-K Annual Report on Form 10-K or Quarterly Reports on Form 10-Q for the period affected by the restatement. The financial information that has been previously filed or otherwise reported for these periods is superseded by the information in this Annual Report on Form 10-K, and the financial statements and related financial information contained in such previously filed reports should no longer be relied upon. The restatement is more fully described in Note 2 of the notes to the financial statements included herein.
Class A ordinary
Document and Entity Information
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	CHFW
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		4,025,962
Class B ordinary
Document and Entity Information
Entity Common Stock, Shares Outstanding		2,300,000
Units, each consisting of one share of Class A ordinary shares, and one-third of a redeemable Warrant to acquire one Class A ordinary share
Document and Entity Information
Title of 12(b) Security	units, each consisting of one Class A ordinary share and one-third of a warrant to acquire one Class A ordinary share
Trading Symbol	CHFW.U
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		5,584,038
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Document and Entity Information
Title of 12(b) Security	Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	CHFW.W
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		1,366,280

BALANCE SHEET

BALANCE SHEET	Dec. 31, 2020USD ($)
Current Assets
Cash	$ 987,187
Prepaid expenses	790,341
Total Current Assets	1,777,528
Cash and marketable securities held in Trust Account	91,997,501
Total Assets	93,775,029
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities - accrued expenses	290,148
Warrant Liability	3,404,014
Deferred underwriting fee payable	3,220,000
Total Liabilities	6,914,162
Commitments
Class A ordinary shares subject to possible redemption, 8,186,086 shares at redemption value	81,860,860
Stockholder's Equity
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital	7,121,960
Accumulated deficit	(2,122,328)
Total Stockholder's Equity	5,000,007
Total Liabilities and Shareholders' Equity	93,775,029
Class A ordinary
Stockholder's Equity
Common stock	145
Class B ordinary
Stockholder's Equity
Common stock	$ 230

BALANCE SHEET (Parenthetical)

BALANCE SHEET (Parenthetical)	Dec. 31, 2020$ / sharesshares
Temporary equity, shares outstanding	8,186,086
Preferred stock, par value, (per share) | $ / shares	$ 0.0001
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Class A ordinary
Common shares, par value, (per share) | $ / shares	$ 0.0001
Common shares, shares authorized	350,000,000
Common shares, shares issued	1,447,914
Common shares, shares outstanding	1,447,914
Class B ordinary
Common shares, par value, (per share) | $ / shares	$ 0.0001
Common shares, shares authorized	150,000,000
Common shares, shares issued	2,300,000
Common shares, shares outstanding	2,300,000

STATEMENT OF OPERATIONS

STATEMENT OF OPERATIONS	4 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Formation and operational costs	$ 438,756
Loss from operations	(438,756)
Other income:
Interest earned on marketable securities held in Trust Account	5,892
Transaction costs associated with initial public offering	(107,519)
Change in fair value of warrant liability	(1,573,554)
Unrealized loss on marketable securities held in Trust Account	(8,391)
Other loss, net	(1,683,572)
Net loss	(2,122,328)
Class A ordinary shares subject to possible
Other income:
Interest earned on marketable securities held in Trust Account	5,243
Unrealized loss on marketable securities held in Trust Account	$ (7,466)
Basic and diluted weighted average shares outstanding | shares	8,181,335
Basic and diluted net loss per share | $ / shares	$ 0
Non-redeemable ordinary shares
Other income:
Net loss	$ (2,122,328)
Basic and diluted weighted average shares outstanding | shares	2,461,095
Basic and diluted net loss per share | $ / shares	$ (0.86)

STATEMENT OF CHANGES IN STOCKHO

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - 4 months ended Dec. 31, 2020 - USD ($)	Total	Additional Paid-in Capital	Accumulated Deficit	Class A ordinaryCommon Stock	Class B ordinaryCommon Stock
Balance at the beginning at Aug. 20, 2020	$ 0	$ 0	$ 0	$ 0	$ 0
Balance at the beginning (in shares) at Aug. 20, 2020				0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Aggregate purchase price	25,000	24,770			$ 230
Issuance of Class B ordinary shares to Sponsor(1) (in shares)					2,300,000
Sale of Units, net of underwriting discounts, offering costs and warrant liability	$ 86,113,691	86,112,771		$ 920
Sale of Units, net of underwriting discounts, offering costs and warrant liability (in shares)	9,200,000			9,200,000
Sale of Private Placement Units, net of warrant liability	$ 2,844,504	2,844,461		$ 43
Sale of Private Placement Units, net of warrant liability (in shares)				434,000
Class A ordinary shares subject to possible redemption	(81,860,860)	(81,860,042)		$ (818)
Class A ordinary shares subject to possible redemption (in shares)				(8,186,086)
Net loss	(2,122,328)		(2,122,328)
Balance at the end at Dec. 31, 2020	$ 5,000,007	$ 7,121,960	$ (2,122,328)	$ 145	$ 230
Balance at the end (in shares) at Dec. 31, 2020				1,447,914	2,300,000

STATEMENT OF CHANGES IN STOCK_2

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical)	4 Months Ended
	Dec. 31, 2020shares
STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY
Sale of Units, net of underwriting discounts, offering costs and warrant liability (in shares)	9,200,000
Sale of Private Placement Units, net of warrant liability	434,000

STATEMENT OF CASH FLOWS

STATEMENT OF CASH FLOWS	4 Months Ended
	Dec. 31, 2020USD ($)
Cash Flows from Operating Activities:
Net loss	$ (2,122,328)
Adjustments to reconcile net loss to net cash used in operating activities:
Payment of formation costs through issuance of Class B ordinary shares	4,961
Interest earned on marketable securities held in Trust Account	(5,892)
Change in fair value of warrant liability	1,573,554
Transaction costs in connection with the initial public offering	107,519
Unrealized loss on marketable securities held in Trust Account	8,391
Changes in operating assets and liabilities:
Prepaid expenses	(790,341)
Accrued expenses	290,148
Net cash used in operating activities	(933,988)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(92,000,000)
Net cash used in investing activities	(92,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	90,160,000
Proceeds from sale of Private Placement Units	4,340,000
Proceeds from promissory note - related party	147,753
Repayment of promissory note - related party	(147,753)
Payment of offering costs	(578,825)
Net cash provided by financing activities	93,921,175
Net Change in Cash	987,187
Cash - Ending	987,187
Non-Cash Investing and Financing Activities:
Initial classification of Class A ordinary shares subject to possible redemption	72,522,937
Change in value of Class A ordinary shares subject to possible redemption	(2,429,850)
Initial classification of warrant liability	1,830,460
Offering costs paid directly by Sponsor from proceeds from issuance of Class B ordinary shares	20,039
Deferred underwriting fee payable	$ 3,220,000

DESCRIPTION OF ORGANIZATION AND

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	4 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Consonance-HFW The Company is not limited to a particular industry or geographic region for purposes of completing a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of December 31, 2020, the Company had not commenced any operations. All activity for the period from August 21, 2020 (inception) through December 31, 2020 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating The registration statement for the Company’s Initial Public Offering became effective on November 18, 2020. On November 23, 2020, the Company consummated the Initial Public Offering of 8,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $80,000,000 which is described in Note 4 Simultaneously with the consummation of the Initial Public Offering, the Company consummated the sale of 410,000 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to Consonance Life Sciences (the “Sponsor”), generating gross proceeds of $4,100,000, which is described in Note 5. Following the consummation of the Initial Public Offering on November 23, 2020, an amount of $80,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of Rule 2a-7 On December 1, 2020, the underwriters fully exercised their over-allotment option, resulting in an additional 1,200,000 Units issued for an aggregate amount of $12,000,000. In connection with the underwriters’ full exercise of their over-allotment option, the Company also consummated the sale of an additional 24,000 Private Placement Units at $10.00 per Private Placement Unit, generating total proceeds of $12,240,000. A total of $12,000,000 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $92,000,000. Transaction costs amounted to $5,658,864, consisting of $1,840,000 of underwriting fees, $3,220,000 of deferred underwriting fees and $598,864 of other offering costs. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding any deferred underwriting commissions held in the Trust Account and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19

RESTATEMENT OF PREVIOUSLY ISSUE

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	4 Months Ended
	Dec. 31, 2020
Restatement [Abstract]
Restatement Of Previously Issued Financial Statements	NOTE 2 — RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS The Company previously accounted for its outstanding Public Warrants (as defined in Note 4) and Private Placement Warrants issued in connection with its Initial Public Offering as components of equity instead of as derivative liabilities. The warrant agreement governing the warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. In addition, the warrant agreement includes a provision that in the event of a tender or exchange offer made to and accepted by holders of more than 50% of the outstanding shares of a single class of ordinary shares, all holders of the warrants would be entitled to receive cash for their warrants (the “tender offer provision”). In connection with the audit of the Company’s financial statements for the period ended December 31, 2020, the Company’s management further evaluated the warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Section 815-40-15 Section 815-40-15, Section 815-40-15 fixed-for-fixed Section 815-40-25. As a result of the above, the Company should have classified the warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period. The Company’s accounting for the warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported operating expenses, cash or investments held in the trust account. As Previously As Reported Adjustments Restated Balance sheet as of November 23, 2020 (audited) Warrant Liability $ — $ 1,598,233 $ 1,598,233 Total Liabilities 3,167,722 1,598,233 4,765,955 Ordinary Shares Subject to Possible Redemption 74,121,170 (1,598,233 ) 72,522,937 Class A Ordinary Shares 100 18 118 Additional Paid-in 5,004,636 107,501 5,112,137 Accumulated Deficit (4,961 ) (107,519 ) (112,480 ) Balance sheet as of December 31, 2020 (audited) Warrant Liability $ — $ 3,404,014 $ 3,404,014 Total Liabilities 3,510,148 3,404,014 6,914,162 Ordinary Shares Subject to Possible Redemption 85,264,880 (3,404,020 ) 81,860,860 Class A Ordinary Shares 111 34 145 Additional Paid-in 5,440,915 1,681,045 7,121,960 Accumulated Deficit (441,255 ) (1,681,073 ) (2,122,328 ) Shareholders’ Equity 5,000,001 6 5,000,007 Period from August 20, 2020 (inception) to December 31, 2020 (audited) Change in fair value of warrant liability $ — $ 1,573,554 $ 1,573,554 Allocation of initial public offering costs — 107,519 107,519 Net loss (441,255 ) (1,681,073 ) (2,122,328 ) Weighted average shares outstanding of Class A redeemable ordinary shares 8,326,328 (144,993 ) 8,181,335 Weighted average shares outstanding of Class B non-redeemable 2,414,403 46,692 2,461,095 Basic and diluted net loss per share, Class B (0.18 ) (0.68 ) (0.86 ) Cash Flow Statement for the Period from August 20, 2020 (inception) to December 31, 2020 (audited) Net loss $ (441,255 ) $ (1,681,073 ) $ (2,122,328 ) Allocation of initial public offering costs — 107,519 107,519 Change in fair value of warrant liability — 1,573,554 1,573,554 Initial classification of warrant liability — 1,830,460 1,830,460 Initial classification of common stock subject to possible redemption 74,121,170 (1,598,233 ) 72,522,937 Change in value of common stock subject to possible redemption (436,290 ) (1,993,560 ) (2,429,850 )

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	4 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020. Marketable Securities Held in Trust Account At December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. Warrant Liability The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not The Company is considered an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. Net Income (Loss) Per Share Net income (loss) per share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 3,211,334 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company’s statement of operations includes a presentation of income (loss) per share for ordinary shares subject to possible redemption in a manner similar to the two-class Net income (loss) per share, basic and diluted, for non-redeemable non-redeemable Non-redeemable non-redeemable Non-redeemable non-redeemable The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the from August 21, (Inception) Through December 31, 2020 Ordinary shares subject to possible redemption Numerator: Earnings allocable to Ordinary shares subject to possible redemption Interest earned on marketable securities held in Trust Account $ 5,243 Unrealized gain (loss) on marketable securities held in Trust Account (7,466 ) Net income attributable to Class A ordinary shares subject to possible redemption $ (2,223 ) Denominator: Weighted Average Class A ordinary shares subject to possible redemption Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption 8,181,335 Basic and diluted net loss per share, Class A ordinary shares subject to possible redemption $ 0.00 Non-Redeemable Numerator: Net Loss minus Net Earnings Net loss $ (2,122,328 ) Add: Net loss allocable to Class A ordinary shares subject to possible redemption 2,223 Non-Redeemable $ (2,120,105 ) Denominator: Weighted Average Non-redeemable Basic and diluted weighted average shares outstanding, Non-redeemable 2,461,095 Basic and diluted net loss per share, Non-redeemable $ (0.86 ) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	4 Months Ended
	Dec. 31, 2020
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING	NOTE 4. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 8,000,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-third On December 1, 2020, the underwriters fully exercised their over-allotment option, resulting in an additional 1,200,000 Units issued for an aggregate amount of $12,000,000. In connection with the underwriters’ full exercise of their over-allotment option, the Company also consummated the sale of an additional 24,000 Private Placement Units at $10.00 per Private Placement Unit, generating total proceeds of $12,240,000. A total of $12,000,000 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $92,000,000 (see Note 9).

PRIVATE PLACEMENT

PRIVATE PLACEMENT	4 Months Ended
	Dec. 31, 2020
PRIVATE PLACEMENT
PRIVATE PLACEMENT	NOTE 5. PRIVATE PLACEMENT Simultaneously with the consummation of the Initial Public Offering, the Sponsor purchased an aggregate of 410,000 Private Placement Units at a price of $10.00 per Private Placement Unit, for an aggregate purchase price of $4,100,000. On December 1, 2020, as a result of the underwriters’ election to fully exercise their over-allotment option, the Sponsor purchased an additional 24,000 Private Placement Units, at a price of $10.00 per Private Placement Unit, or $240,000 in the aggregate. Each Private Placement Unit consists of one Class A ordinary share (“Private Placement Share” or, collectively, “Private Placement Shares”) and one-third

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	4 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares On September 4, 2020, the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for 3,593,750 Class B ordinary shares. On October 8, 2020 and November 10, 2020, 718,750 and 575,000 Class B ordinary shares were contributed back to the Company for no consideration, respectively, resulting in there being 2,300,000 Class B ordinary shares (the “Founder Shares”) being issued and outstanding. The Founder Shares include an aggregate of up to 300,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the number of Founder Shares will collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering (not including the Private Placement Shares). On December 1, 2020, the underwriters fully exercised their over-allotment option, therefore there are no Founder Shares subject to forfeiture. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, 30-trading Administrative Services Agreement The Company entered into an agreement, commencing on November 18, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay the Sponsor a total of up to $55,000 per month for office space and administrative support services. For the period from August 21, 2020 (inception) through December 31, 2020, the Company incurred and paid $55,000 of such fees. Promissory Note — Related Party On September 4, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into Private Placement Units of the post-Business Combination entity at a price of $10.00 per Private Placement Unit. The Private Placement Units would be identical to the Units. As of December 31, 2020, the Company had no outstanding borrowings under the Working Capital Loans.

COMMITMENTS

COMMITMENTS	4 Months Ended
	Dec. 31, 2020
COMMITMENTS
COMMITMENTS	NOTE 7. COMMITMENTS Registration and Shareholder Rights Pursuant to a registration rights agreement entered into on November 18, 2020, the holders of the Founder Shares, Private Placement Units (including securities contained therein) and warrants that may be issued upon conversion of the Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Units and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up Underwriting Agreement The underwriters are entitled to a deferred fee of $0.35 per Unit, or $3,220,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	4 Months Ended
	Dec. 31, 2020
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' EQUITY	NOTE 8. SHAREHOLDERS’ EQUITY Preference shares — Class A ordinary shares — Class B ordinary shares — Only holders of the Class B ordinary shares will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of the Company’s shareholders except as otherwise required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the consummation of a Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted

WARRANTS

WARRANTS	4 Months Ended
	Dec. 31, 2020
Stockholders' Equity Note [Abstract]
WARRANTS	NOTE 9. Warrants Warrants — one five The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating thereto is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available. The Company has agreed that as soon as practicable, but in no event later than 20 business days, after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of a Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement; if the Class A ordinary shares are, at the time of any exercise of a warrant, not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 • in whole and not in part; • at a price of $0.01 per Public Warrant; • upon not less than 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, 30-trading If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company are unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00 • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that during such 30 day period holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares, based on the redemption date and the fair market value of the Class A ordinary shares, that if the warrants are not exercised on a cashless basis or otherwise during such 30 day period, the Company shall redeem such warrants for $0.10 per share; • if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like) on the trading day before the Company sends the notice of redemption to the warrant holders; and • if the Reference Value is less than $18.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable,

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	4 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 10 The Company follows the guidance in ASC Topic 820 for its financial assets and liabilities that are re-measured non-financial re-measured The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, 2020 Assets: Marketable securities held in Trust Account 1 $ 91,997,501 Liabilities: Warrant Liability – Public Warrants 1 3,250,667 Warrant Liability – Private Placement Warrants 3 153,347 The Warrants were accounted for as liabilities in accordance with ASC 815-40 Initial Measurement Both the Private Placement Warrants and the Public Warrants were initially valued using a binomial lattice model, which is considered to be a Level 3 fair value measurement. The binomial lattice model’s primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the common stock. The expected volatility as of the IPO date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates will be implied from the Company’s own public warrant pricing. A binomial lattice model methodology was also used in estimating the fair value of the Public Warrants for periods where no observable traded price was available, using the same expected volatility as was used in measuring the fair value of the Private Placement Warrants. For periods subsequent to the detachment of the Warrants from the Units, the close price of the Public Warrant price will be used as the fair value as of each relevant date. The key inputs into the binomial lattice simulation model for the Private Placement Warrants and Public Warrants were as follows at initial measurement: Input November 23, December 1 Risk-free interest rate 0.4 % 0.4 % Expected term (years)5 5 5 Expected volatility 12.0 % 16 % Exercise price $ 11.50 $ 11.50 Fair value of Units $ 9.81 $ 10.12 On November 23, 2020, the Private Placement Warrants and Public Warrants were determined to be $.57 per warrant for aggregate values of $82,460 and $1,748,000, respectively (these values include the underwriters exercise of their overallotment option on December 1, 2020). Subsequent Measurement The Warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of December 31, 2020 is classified as Level 1 due to the use of an observable market quote in an active market. As of December 31, 2020, the aggregate values of the Private Placement Warrants and Public Warrants were $153,347 and $3,250,667 million, respectively. The following table presents the changes in the fair value of warrant liabilities: Private Placement Public Warrant Liabilities $ — $ — $ — Initial measurement on November 23, 2020 77,900 1,520,000 1,597,900 Change in valuation inputs or other assumptions 75,447 1,730,667 1,806,114 Fair value as of December 31, 2020 $ 153,347 $ 3,250,667 $ 3,404,014 Due to the use of quoted prices in an active market (Level 1) to measure the fair value of the Public Warrants, subsequent to initial measurement, the Company had transfers out of Level 3 totaling $1,597,900 during the period from November 23, 2020 through December 31, 2020.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	4 Months Ended
	Dec. 31, 2020
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 11. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, except as noted in footnote 2 and as set forth below , the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. Business Combination Agreement and PIPE Financing On April 15, 2021, the Company entered into a business combination agreement with Surrozen, Inc. (“Surrozen”), pursuant to which a wholly-owned subsidiary of the Company will merge with and into Surrozen, with Surrozen surviving as a wholly-owned subsidiary of the Company and the Company will redomicile as a Delaware corporation. In accordance with the terms and subject to the conditions of the Business Combination Agreement, each share and equity award (whether vested or unvested) of Surrozen outstanding as of closing will be exchanged for shares of the Company’s common stock or comparable equity awards that are settled or are exercisable for shares of the Company’s common stock, as applicable, based on an implied Surrozen equity value of $200,000,000 and a $10.00 per share value of the Company’s Common Stock. In connection with the foregoing and concurrently with the execution of the Business Combination Agreement, the Company entered into Subscription Agreements with certain investors (the “Subscription Agreements” and such investors, the “PIPE Investors”), pursuant to which the PIPE Investors have agreed to subscribe for and purchase, and the Company has agreed to issue and sell to the PIPE Investors, an aggregate of 12,020,000 units, each consisting of one share of the Company’s common stock and one-third of one redeemable warrant for one share of the Company’s common stock (the “PIPE Warrants”), for a purchase price of $10.00 per unit (the “PIPE Units”), for aggregate gross proceeds of $120,200,000 (the “PIPE Financing”). Each whole PIPE Warrant entitles the holder thereof to purchase one share of the Company’s common stock at a price of $11.50 per share, subject to adjustment as described in the form of warrant agreement attached to the form of Subscription Agreement, and only whole PIPE Warrants will be exercisable. The PIPE Warrants have substantially the same provisions as the warrants issued in connection with the Company’s initial public offering. The securities to be issued pursuant to the Subscription Agreements have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) in reliance upon the exemption provided in Section 4(a)(2) of the Securities Act. (As of May 14, 2021)

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	4 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020.
Marketable Securities Held in Trust Account	Marketable Securities Held in Trust Account At December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills.
Warrant Liability	Warrant Liability The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not The Company is considered an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.
Net Loss per Ordinary Share	Net Income (Loss) Per Share Net income (loss) per share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 3,211,334 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company’s statement of operations includes a presentation of income (loss) per share for ordinary shares subject to possible redemption in a manner similar to the two-class Net income (loss) per share, basic and diluted, for non-redeemable non-redeemable Non-redeemable non-redeemable Non-redeemable non-redeemable The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the from August 21, (Inception) Through December 31, 2020 Ordinary shares subject to possible redemption Numerator: Earnings allocable to Ordinary shares subject to possible redemption Interest earned on marketable securities held in Trust Account $ 5,243 Unrealized gain (loss) on marketable securities held in Trust Account (7,466 ) Net income attributable to Class A ordinary shares subject to possible redemption $ (2,223 ) Denominator: Weighted Average Class A ordinary shares subject to possible redemption Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption 8,181,335 Basic and diluted net loss per share, Class A ordinary shares subject to possible redemption $ 0.00 Non-Redeemable Numerator: Net Loss minus Net Earnings Net loss $ (2,122,328 ) Add: Net loss allocable to Class A ordinary shares subject to possible redemption 2,223 Non-Redeemable $ (2,120,105 ) Denominator: Weighted Average Non-redeemable Basic and diluted weighted average shares outstanding, Non-redeemable 2,461,095 Basic and diluted net loss per share, Non-redeemable $ (0.86 )
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying financial statements.

RESTATEMENT OF PREVIOUSLY ISS_2

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)	4 Months Ended
	Dec. 31, 2020
Restatement [Abstract]
Summary of restatement of previously issued financial statements	The Company’s accounting for the warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported operating expenses, cash or investments held in the trust account. As Previously As Reported Adjustments Restated Balance sheet as of November 23, 2020 (audited) Warrant Liability $ — $ 1,598,233 $ 1,598,233 Total Liabilities 3,167,722 1,598,233 4,765,955 Ordinary Shares Subject to Possible Redemption 74,121,170 (1,598,233 ) 72,522,937 Class A Ordinary Shares 100 18 118 Additional Paid-in 5,004,636 107,501 5,112,137 Accumulated Deficit (4,961 ) (107,519 ) (112,480 ) Balance sheet as of December 31, 2020 (audited) Warrant Liability $ — $ 3,404,014 $ 3,404,014 Total Liabilities 3,510,148 3,404,014 6,914,162 Ordinary Shares Subject to Possible Redemption 85,264,880 (3,404,020 ) 81,860,860 Class A Ordinary Shares 111 34 145 Additional Paid-in 5,440,915 1,681,045 7,121,960 Accumulated Deficit (441,255 ) (1,681,073 ) (2,122,328 ) Shareholders’ Equity 5,000,001 6 5,000,007 Period from August 20, 2020 (inception) to December 31, 2020 (audited) Change in fair value of warrant liability $ — $ 1,573,554 $ 1,573,554 Allocation of initial public offering costs — 107,519 107,519 Net loss (441,255 ) (1,681,073 ) (2,122,328 ) Weighted average shares outstanding of Class A redeemable ordinary shares 8,326,328 (144,993 ) 8,181,335 Weighted average shares outstanding of Class B non-redeemable 2,414,403 46,692 2,461,095 Basic and diluted net loss per share, Class B (0.18 ) (0.68 ) (0.86 ) Cash Flow Statement for the Period from August 20, 2020 (inception) to December 31, 2020 (audited) Net loss $ (441,255 ) $ (1,681,073 ) $ (2,122,328 ) Allocation of initial public offering costs — 107,519 107,519 Change in fair value of warrant liability — 1,573,554 1,573,554 Initial classification of warrant liability — 1,830,460 1,830,460 Initial classification of common stock subject to possible redemption 74,121,170 (1,598,233 ) 72,522,937 Change in value of common stock subject to possible redemption (436,290 ) (1,993,560 ) (2,429,850 )

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	4 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Schedule of basic and diluted net income (loss) per ordinary share	The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the from August 21, (Inception) Through December 31, 2020 Ordinary shares subject to possible redemption Numerator: Earnings allocable to Ordinary shares subject to possible redemption Interest earned on marketable securities held in Trust Account $ 5,243 Unrealized gain (loss) on marketable securities held in Trust Account (7,466 ) Net income attributable to Class A ordinary shares subject to possible redemption $ (2,223 ) Denominator: Weighted Average Class A ordinary shares subject to possible redemption Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption 8,181,335 Basic and diluted net loss per share, Class A ordinary shares subject to possible redemption $ 0.00 Non-Redeemable Numerator: Net Loss minus Net Earnings Net loss $ (2,122,328 ) Add: Net loss allocable to Class A ordinary shares subject to possible redemption 2,223 Non-Redeemable $ (2,120,105 ) Denominator: Weighted Average Non-redeemable Basic and diluted weighted average shares outstanding, Non-redeemable 2,461,095 Basic and diluted net loss per share, Non-redeemable $ (0.86 )

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	4 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Schedule of company's assets that are measured at fair value on a recurring basis	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, 2020 Assets: Marketable securities held in Trust Account 1 $ 91,997,501 Liabilities: Warrant Liability – Public Warrants 1 3,250,667 Warrant Liability – Private Placement Warrants 3 153,347
Summary of key Inputs into the Binomial Lattice Simulation Model for the Private Placement Warrants and Public Warrants	The key inputs into the binomial lattice simulation model for the Private Placement Warrants and Public Warrants were as follows at initial measurement: Input November 23, December 1 Risk-free interest rate 0.4 % 0.4 % Expected term (years)5 5 5 Expected volatility 12.0 % 16 % Exercise price $ 11.50 $ 11.50 Fair value of Units $ 9.81 $ 10.12
Summary of fair value of the warrant liabilities	The following table presents the changes in the fair value of warrant liabilities: Private Placement Public Warrant Liabilities $ — $ — $ — Initial measurement on November 23, 2020 77,900 1,520,000 1,597,900 Change in valuation inputs or other assumptions 75,447 1,730,667 1,806,114 Fair value as of December 31, 2020 $ 153,347 $ 3,250,667 $ 3,404,014

DESCRIPTION OF ORGANIZATION A_2

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)	Dec. 01, 2020USD ($)$ / sharesshares	Nov. 23, 2020USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares
Subsidiary, Sale of Stock [Line Items]
Condition for future business combination number of businesses minimum			1
Sale of Units, net of underwriting discounts | shares			9,200,000
Proceeds from issuance of units	$ 12,240,000		$ 86,113,691
Assets Held-in-trust	92,000,000
Additions to assets held in trust	$ 12,000,000
Transaction Costs			5,658,864
Underwriting fees			1,840,000
Deferred underwriting fee payable			3,220,000
Other offering costs			$ 598,864
Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account			80.00%
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination			50.00%
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts | shares		8,000,000
Share price | $ / shares		$ 10	$ 10
Proceeds from issuance of units		$ 80,000,000
Assets Held-in-trust		$ 80,000,000
Private Placement
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts | shares	24,000	410,000
Share price | $ / shares	$ 10	$ 10
Proceeds from issuance of units	$ 240,000	$ 4,100,000
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts | shares	1,200,000
Proceeds from issuance of units	$ 12,000,000

RESTATEMENT OF PREVIOUSLY ISS_3

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Additional Information (Details)	4 Months Ended
	Dec. 31, 2020
Restatement [Abstract]
Percentage of minimum acceptance of shareholders of tender offer provision	50.00%

RESTATEMENT OF PREVIOUSLY ISS_4

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Summary of restatement of previously issued financial statements (Details) - USD ($)	4 Months Ended
	Dec. 31, 2020	Dec. 31, 2020	Nov. 23, 2020	Aug. 20, 2020
Prior Period Restatement Of Balance Sheet [Abstract]
Warrant Liability	$ 3,404,014	$ 3,404,014
Total Liabilities	6,914,162	6,914,162
Ordinary Shares Subject to Possible Redemption	81,860,860	81,860,860
Additional paid-in capital	7,121,960	7,121,960
Accumulated deficit	(2,122,328)	(2,122,328)
Shareholders' Equity	5,000,007	5,000,007		$ 0
Prior Period Adjustment Restatement of Statement Of Operations [Abstract]
Change in fair value of warrant liability	1,573,554
Net loss	(2,122,328)
Prior Period Adjustment Restatement Of Statement Of Cash Flows [Abstract]
Net loss	(2,122,328)
Change in fair value of warrant liability	1,573,554
Initial classification of warrant liability	1,830,460
Initial classification of common stock subject to possible redemption	72,522,937
Change in value of common stock subject to possible redemption	(2,429,850)
Class A ordinary
Prior Period Restatement Of Balance Sheet [Abstract]
Class A Ordinary Shares	$ 145	145
Class A ordinary shares subject to possible
Prior Period Adjustment Restatement of Statement Of Operations [Abstract]
weighted average shares outstanding	8,181,335
Basic and diluted net loss per share	$ 0
Non-redeemable ordinary shares
Prior Period Adjustment Restatement of Statement Of Operations [Abstract]
Net loss	$ (2,122,328)
weighted average shares outstanding	2,461,095
Basic and diluted net loss per share	$ (0.86)
Prior Period Adjustment Restatement Of Statement Of Cash Flows [Abstract]
Net loss	$ (2,122,328)
As Previously Reported
Prior Period Restatement Of Balance Sheet [Abstract]
Total Liabilities	3,510,148	3,510,148	$ 3,167,722
Ordinary Shares Subject to Possible Redemption	85,264,880	85,264,880	74,121,170
Additional paid-in capital	5,440,915	5,440,915	5,004,636
Accumulated deficit	(441,255)	(441,255)	(4,961)
Shareholders' Equity	5,000,001	5,000,001
Prior Period Adjustment Restatement of Statement Of Operations [Abstract]
Net loss		(441,255)
Prior Period Adjustment Restatement Of Statement Of Cash Flows [Abstract]
Net loss		(441,255)
Initial classification of common stock subject to possible redemption		74,121,170
Change in value of common stock subject to possible redemption		(436,290)
As Previously Reported | Class A ordinary
Prior Period Restatement Of Balance Sheet [Abstract]
Class A Ordinary Shares	111	$ 111	100
As Previously Reported | Class A ordinary shares subject to possible
Prior Period Adjustment Restatement of Statement Of Operations [Abstract]
weighted average shares outstanding		8,326,328
As Previously Reported | Non-redeemable ordinary shares
Prior Period Adjustment Restatement of Statement Of Operations [Abstract]
weighted average shares outstanding		2,414,403
Basic and diluted net loss per share		$ (0.18)
Adjustments
Prior Period Restatement Of Balance Sheet [Abstract]
Warrant Liability	3,404,014	$ 3,404,014	1,598,233
Total Liabilities	3,404,014	3,404,014	1,598,233
Ordinary Shares Subject to Possible Redemption	(3,404,020)	(3,404,020)	(1,598,233)
Additional paid-in capital	1,681,045	1,681,045	107,501
Accumulated deficit	(1,681,073)	(1,681,073)	(107,519)
Shareholders' Equity	6	6
Prior Period Adjustment Restatement of Statement Of Operations [Abstract]
Change in fair value of warrant liability		1,573,554
Allocation of initial public offering costs		107,519
Net loss		(1,681,073)
Prior Period Adjustment Restatement Of Statement Of Cash Flows [Abstract]
Net loss		(1,681,073)
Allocation of initial public offering costs		107,519
Change in fair value of warrant liability		1,573,554
Initial classification of warrant liability		1,830,460
Initial classification of common stock subject to possible redemption		(1,598,233)
Change in value of common stock subject to possible redemption		(1,993,560)
Adjustments | Class A ordinary
Prior Period Restatement Of Balance Sheet [Abstract]
Class A Ordinary Shares	34	$ 34	18
Adjustments | Class A ordinary shares subject to possible
Prior Period Adjustment Restatement of Statement Of Operations [Abstract]
weighted average shares outstanding		(144,993)
Adjustments | Non-redeemable ordinary shares
Prior Period Adjustment Restatement of Statement Of Operations [Abstract]
weighted average shares outstanding		46,692
Basic and diluted net loss per share		$ (0.68)
As Restated
Prior Period Restatement Of Balance Sheet [Abstract]
Warrant Liability	3,404,014	$ 3,404,014	1,598,233
Total Liabilities	6,914,162	6,914,162	4,765,955
Ordinary Shares Subject to Possible Redemption	81,860,860	81,860,860	72,522,937
Additional paid-in capital	7,121,960	7,121,960	5,112,137
Accumulated deficit	(2,122,328)	(2,122,328)	(112,480)
Shareholders' Equity	5,000,007	5,000,007
Prior Period Adjustment Restatement of Statement Of Operations [Abstract]
Change in fair value of warrant liability		1,573,554
Allocation of initial public offering costs		107,519
Net loss		(2,122,328)
Prior Period Adjustment Restatement Of Statement Of Cash Flows [Abstract]
Net loss		(2,122,328)
Allocation of initial public offering costs		107,519
Change in fair value of warrant liability		1,573,554
Initial classification of warrant liability		1,830,460
Initial classification of common stock subject to possible redemption		72,522,937
Change in value of common stock subject to possible redemption		(2,429,850)
As Restated | Class A ordinary
Prior Period Restatement Of Balance Sheet [Abstract]
Class A Ordinary Shares	$ 145	$ 145	$ 118
As Restated | Class A ordinary shares subject to possible
Prior Period Adjustment Restatement of Statement Of Operations [Abstract]
weighted average shares outstanding		8,181,335
As Restated | Non-redeemable ordinary shares
Prior Period Adjustment Restatement of Statement Of Operations [Abstract]
weighted average shares outstanding		2,461,095
Basic and diluted net loss per share		$ (0.86)

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	Dec. 31, 2020USD ($)shares
Unrecognized tax benefits	$ 0
Amounts accrued for the payment of interest and penalties	0
Federal Depository Insurance Coverage	$ 250,000
Number of warrants to purchase shares issued | shares	434,000
Initial Public Offering and private placement
Number of warrants to purchase shares issued | shares	3,211,334

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Basic and diluted net income (loss) per ordinary share (Details)	4 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Net loss	$ (2,122,328)
Interest earned on marketable securities held in Trust Account	5,892
Unrealized gain (loss) on marketable securities held in Trust Account	(8,391)
Class A ordinary shares subject to possible
Interest earned on marketable securities held in Trust Account	5,243
Unrealized gain (loss) on marketable securities held in Trust Account	(7,466)
Net income (loss) attributable to holder	$ (2,223)
Basic and diluted weighted average shares outstanding | shares	8,181,335
Basic and diluted net loss per share | $ / shares	$ 0
Non-redeemable ordinary shares
Net loss	$ (2,122,328)
Add: Net loss allocable to Class A ordinary shares subject to possible redemption	2,223
Net income (loss) attributable to holder	$ (2,120,105)
Basic and diluted weighted average shares outstanding | shares	2,461,095
Basic and diluted net loss per share | $ / shares	$ (0.86)

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details) - USD ($)	Dec. 01, 2020	Nov. 23, 2020	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Sale of Units (in shares)			9,200,000
Proceeds from issuance of units	$ 12,240,000		$ 86,113,691
Additions to assets held in trust	12,000,000
Assets Held-in-trust	$ 92,000,000
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of Units (in shares)		8,000,000
Share price		$ 10	$ 10
Proceeds from issuance of units		$ 80,000,000
Assets Held-in-trust		$ 80,000,000
Initial Public Offering | Public Warrants
Subsidiary, Sale of Stock [Line Items]
Shares per unit		1
Warrants per unit		0.33
Shares per warrant		1
Exercise price of warrants		$ 11.50
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Sale of Units (in shares)	1,200,000
Proceeds from issuance of units	$ 12,000,000
Private Placement
Subsidiary, Sale of Stock [Line Items]
Sale of Units (in shares)	24,000	410,000
Share price	$ 10	$ 10
Shares per unit	1
Proceeds from issuance of units	$ 240,000	$ 4,100,000

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details) - USD ($)	Dec. 01, 2020	Nov. 23, 2020	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Sale of Units (in shares)			9,200,000
Proceeds from issuance of units	$ 12,240,000		$ 86,113,691
Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Warrants per unit	1
Exercise price of warrant	$ 11.50
Private Placement
Subsidiary, Sale of Stock [Line Items]
Sale of Units (in shares)	24,000	410,000
Share price	$ 10	$ 10
Proceeds from issuance of units	$ 240,000	$ 4,100,000
Shares per unit	1
Private Placement | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Warrants per unit	0.33

RELATED PARTY TRANSACTIONS - Fo

RELATED PARTY TRANSACTIONS - Founder Shares (Details)	Nov. 10, 2020USD ($)shares	Oct. 08, 2020USD ($)shares	Sep. 04, 2020USD ($)item$ / sharesshares	Dec. 31, 2020USD ($)shares
Related Party Transaction [Line Items]
Aggregate purchase price | $				$ 25,000
Class B ordinary
Related Party Transaction [Line Items]
Common shares, shares issued (in shares)				2,300,000
Common shares, shares outstanding (in shares)				2,300,000
Class A ordinary
Related Party Transaction [Line Items]
Common shares, shares issued (in shares)				1,447,914
Common shares, shares outstanding (in shares)				1,447,914
Founder Shares | Class B ordinary
Related Party Transaction [Line Items]
Stock repurchased during the period | $	$ 0	$ 0
Stock repurchased during the period ( in shares)	575,000	718,750
Common shares, shares issued (in shares)			2,300,000
Common shares, shares outstanding (in shares)			2,300,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders				20.00%
Founder Shares | Sponsor
Related Party Transaction [Line Items]
Shares subject to forfeiture				300,000
Founder Shares | Sponsor | Class B ordinary
Related Party Transaction [Line Items]
Number of shares issued			3,593,750
Aggregate purchase price | $			$ 25,000
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | item			20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | item			30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences			150 days
Founder Shares | Sponsor | Class A ordinary
Related Party Transaction [Line Items]
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares			$ 12

RELATED PARTY TRANSACTIONS - Ad

RELATED PARTY TRANSACTIONS - Additional Information (Details) - USD ($)	Nov. 18, 2020	Dec. 31, 2020	Nov. 23, 2020	Sep. 04, 2020
Related Party Transaction [Line Items]
Repayment of promissory note - related party		$ 147,753
Promissory Note with Related Party
Related Party Transaction [Line Items]
Maximum borrowing capacity of related party promissory note				$ 300,000
Outstanding balance of related party note			$ 147,753
Administrative Services Agreement
Related Party Transaction [Line Items]
Expenses per month	$ 55,000
Expenses incurred and paid	$ 55,000
Related Party Loans | Working capital loans warrant
Related Party Transaction [Line Items]
Loan conversion agreement warrant		$ 1,500,000
Price of warrant		$ 10

COMMITMENTS (Details)

COMMITMENTS (Details)	Dec. 31, 2020USD ($)$ / shares
COMMITMENTS
Deferred fee per unit | $ / shares	$ 0.35
Deferred underwriting fee payable | $	$ 3,220,000

STOCKHOLDERS' EQUITY - Preferre

STOCKHOLDERS' EQUITY - Preferred Stock Shares (Details)	Dec. 31, 2020$ / sharesshares
Stockholders' Equity Note [Abstract]
Preferred shares, shares authorized	1,000,000
Preferred stock, par value, (per share) | $ / shares	$ 0.0001
Preferred shares, shares issued	0
Preferred shares, shares outstanding	0

STOCKHOLDERS' EQUITY - Common S

STOCKHOLDERS' EQUITY - Common Stock Shares (Details)	Dec. 31, 2020item$ / sharesshares
Class A ordinary
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	350,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001
Common shares, votes per share | item	1
Common shares, shares issued (in shares)	1,447,914
Common shares, shares outstanding (in shares)	1,447,914
Common stock subject to possible redemption, issued (in shares)	8,186,086
Class B ordinary
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	150,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001
Common shares, votes per share | item	1
Common shares, shares issued (in shares)	2,300,000
Common shares, shares outstanding (in shares)	2,300,000
Common stock subject to possible redemption, issued (in shares)	2,300,000

WARRANTS (Details)

WARRANTS (Details)	4 Months Ended
	Dec. 31, 2020itemd$ / shares
Warrants
Class of Warrant or Right [Line Items]
Maximum period after business combination in which to file registration statement	20 days
Period of time within which registration statement is expected to become effective	60 days
Private Placement Warrants
Class of Warrant or Right [Line Items]
Restrictions on transfer period of time after business combination completion	30 days
Public Warrants
Class of Warrant or Right [Line Items]
Warrant exercise period condition one	30 days
Warrant exercise period condition two	1 year
Public Warrants expiration term	5 years
Warrant redemption condition minimum share price scenario two	$ 18
Share price trigger used to measure dilution of warrant	$ 9.20
Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant	60
Trading period after business combination used to measure dilution of warrant | d	20
Warrant exercise price adjustment multiple	115
Warrant redemption price adjustment multiple	100
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Class of Warrant or Right [Line Items]
Warrant redemption condition minimum share price	$ 10
Warrant redemption condition minimum share price scenario two	18
Redemption price per public warrant (in dollars per share)	$ 0.01
Threshold trading days for redemption of public warrants | item	20
Threshold consecutive trading days for redemption of public warrants | item	30
Threshold number of business days before sending notice of redemption to warrant holders | item	3
Redemption period	30 days
Warrant redemption price adjustment multiple	180
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00
Class of Warrant or Right [Line Items]
Warrant redemption condition minimum share price	$ 10
Warrant redemption condition minimum share price scenario two	18
Redemption price per public warrant (in dollars per share)	$ 0.10
Threshold trading days for redemption of public warrants | item	30
Redemption period	30 days

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details)	Dec. 31, 2020USD ($)
Assets:
Marketable securities held in Trust Account	$ 91,997,501
Liabilities:
Warrant Liability	3,404,014
Level 1 | Recurring
Assets:
Marketable securities held in Trust Account	91,997,501
Level 1 | Recurring | Public Warrants
Liabilities:
Warrant Liability	3,250,667
Level 3 | Recurring | Private Placement Warrants
Liabilities:
Warrant Liability	$ 153,347

FAIR VALUE MEASUREMENTS - Summa

FAIR VALUE MEASUREMENTS - Summary of key Inputs into the Binomial Lattice Simulation Model for the Private Placement Warrants and Public Warrants (Details)	Dec. 31, 2020yr	Nov. 23, 2020yr
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, Measurement Input	0.4	0.4
Expected term (years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, Measurement Input	5	5
Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, Measurement Input	16	12
Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, Measurement Input	11.50	11.50
Fair value of Units
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, Measurement Input	10.12	9.81

FAIR VALUE MEASUREMENTS - Sum_2

FAIR VALUE MEASUREMENTS - Summary of fair value of the warrant liabilities (Details)	1 Months Ended
	Dec. 31, 2020USD ($)
Warrants Liabilities
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement on November 23, 2020	$ 1,597,900
Change in valuation inputs or other assumptions	1,806,114
Fair value as of December 31, 2020	3,404,014
Private Placement Warrants
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement on November 23, 2020	77,900
Change in valuation inputs or other assumptions	75,447
Fair value as of December 31, 2020	153,347
Public Warrants
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement on November 23, 2020	1,520,000
Change in valuation inputs or other assumptions	1,730,667
Fair value as of December 31, 2020	$ 3,250,667

FAIR VALUE MEASUREMENTS - Addit

FAIR VALUE MEASUREMENTS - Additional Information (Details) - USD ($)	1 Months Ended
	Dec. 31, 2020	Nov. 23, 2020
Warrants Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Transfers out of level 3	$ 1,597,900
Private Placement Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Aggregate value of warrants	153,347	$ 82,460
Warrants per share		$ 57
Public Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Aggregate value of warrants	$ 3,250,667	$ 1,748,000
Warrants per share		$ 57

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($)	Apr. 15, 2021	Dec. 31, 2020
Proceeds from issuance of warrants		$ 4,340,000
Subscription Agreement [Member] | PIPE Investors [Member]
Stock issued during period shares new shares	12,020,000
Sale of stock price per share	$ 10
Subscription Agreement [Member] | PIPE Investors [Member] | PIPE Warrants [Member]
Proceeds from issuance of warrants	$ 120,200,000
Common Stock [Member] | Subscription Agreement [Member] | PIPE Investors [Member]
Warrant voting right per share	1
Class of warrant or right exercise price of warrants or rights	$ 11.50
Subsequent Event [Member] | Business Combination Agreement [Member]
Business Acquisition equity interest issued or issuable value assigned	$ 200,000,000
Subsequent Event [Member] | Common Stock [Member] | Business Combination Agreement [Member]
Business acquisition share price	$ 10